SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zeneca Group plc (NYSE ticker ZEN) -- Ignore unavailable to you. Want to Upgrade?

To: Steven Messina,L.M.T. who wrote (68)12/9/1998 12:20:00 PM
From: Mac S. Giballa  Respond to of 75
 
congrats on what???



To: Steven Messina,L.M.T. who wrote (68)1/5/1999 11:19:00 PM
From: Henry Niman  Respond to of 75
 
Today's Bloomberg has a story on a potential hostile takeover of ZEN by GLX and tomorrow's FT has a couple of merger stories. One is on a hostile takeover of ZEN by GLX or Roche and the other is on more Merger Mania in Europe. Details linked to the Merger Mania tables at biocognizance.com



To: Steven Messina,L.M.T. who wrote (68)1/6/1999 8:47:00 AM
From: Henry Niman  Respond to of 75
 
DJ is reporting that Chiroscience is up sharply this morning on the rumor that GLX will make a bid for ZEN about 10% higher than the AstraZeneca price, but Bloomberg indicates that Chiroscience price rise is due to anticipated drug approval. Details linked to the Merger Mania page at biocognizance.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News